Gilead: Additional remdesivir data shows improved recovery

Stocks moved slightly higher in the pre-market Friday following Gilead Sciences release of new data Friday on its antiviral drug remdesivir. The data shows the treatment reduced the risk of death for severely sick coronavirus patients by 62% compared with standard care alone. CNBC's "Squawk on the Street" crew discusses why the markets moved on the news and what may come next.
Fri, Jul 10 20209:45 AM EDT